Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Expenditure

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Expenditure History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Expenditure ₹315 Cr₹283 Cr₹252 Cr₹241 Cr₹118 Cr

What is the latest Total Expenditure of NATH BIOGENES (INDIA) ?

The latest Total Expenditure ratio of NATH BIOGENES (INDIA) is ₹315 Cr based on Mar2025 Consolidated results.
Year Total Expenditure
Mar2025₹315 Cr
Mar2024₹283 Cr
Mar2023₹252 Cr
Mar2022₹241 Cr
Mar2013₹118 Cr

How is Total Expenditure of NATH BIOGENES (INDIA) Trending?

Years Total Expenditure % Change
Mar2025 ₹315 Cr
11.42
Mar2024 ₹283 Cr
12.00
Mar2023 ₹252 Cr
4.66
Mar2022 ₹241 Cr
104.70
Mar2013 ₹118 Cr -

Compare Total Expenditure of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹317.0 Cr -1% -4.8% -12.8% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,770.3 Cr -5.4% -4.2% -31% Stock Analytics
KAVERI SEED COMPANY ₹5,503.0 Cr 7.1% 1.1% 15.6% Stock Analytics
VENKYS (INDIA) ₹1,912.2 Cr -0.2% -7.4% -23.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,229.5 Cr -4.1% -3.1% -27.1% Stock Analytics
INDO US BIOTECH ₹258.5 Cr -0.8% -0.3% -48.8% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-1%

-4.8%

-12.8%

SENSEX

1.6%

2.7%

6.3%


You may also like the below Video Courses